Personalized care using thermobalancing therapy can help men with chronic prostatitis and chronic pelvic pain to recover

The incidence of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is high. Thermobalancing therapy (TT) with Dr Allen's Therapeutic Device (DATD) improves the condition of men with CP/CPPS by treating the cause of this disease. The aim of this study is to improve management of CP/CPPS. A clinical trial observed the dynamics of clinical characteristics and parameters in 45 men with CP/CPPS who used DATD, before and after a 6-month period of therapy, and in a no-treatment group. Evaluation used Chronic Prostatitis Symptom Index pain score, quality of life (QoL), and prostate volume (PV). The outcomes confirmed that DATD decreases PV from 31 mL to 27 mL (P < 0.001), reduces pain score from 10.3 to 3.5 (P < 0.001), and improves QoL from 8.1 to 2.9 (P < 0.001), with no changes seen in the control group. Personalized care of patients with CP/CPPS by using TT enables this disease to be effectively and safely managed at home, helping to diminish pharmacological intervention and reduce healthcare costs.